- Home
- BPRN vs TVRD Comparison
BPRN vs TVRD Comparison
Compare BPRN & TVRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPRN
- TVRD
- Stock Information
- Founded
- BPRN 2007
- TVRD 2017
- Country
- BPRN United States
- TVRD United States
- Employees
- BPRN N/A
- TVRD N/A
- Industry
- BPRN Major Banks
- TVRD Biotechnology: Pharmaceutical Preparations
- Sector
- BPRN Finance
- TVRD Health Care
- Exchange
- BPRN Nasdaq
- TVRD Nasdaq
- Market Cap
- BPRN 209.1M
- TVRD 246.5M
- IPO Year
- BPRN N/A
- TVRD N/A
- Fundamental
- Price
- BPRN $32.99
- TVRD $30.44
- Analyst Decision
- BPRN Strong Buy
- TVRD Strong Buy
- Analyst Count
- BPRN 1
- TVRD 5
- Target Price
- BPRN $35.00
- TVRD $59.20
- AVG Volume (30 Days)
- BPRN 7.4K
- TVRD 20.5K
- Earning Date
- BPRN 10-28-2025
- TVRD 08-14-2025
- Dividend Yield
- BPRN 3.64%
- TVRD N/A
- EPS Growth
- BPRN N/A
- TVRD N/A
- EPS
- BPRN 1.00
- TVRD N/A
- Revenue
- BPRN $68,942,000.00
- TVRD N/A
- Revenue This Year
- BPRN $14.18
- TVRD N/A
- Revenue Next Year
- BPRN $15.49
- TVRD N/A
- P/E Ratio
- BPRN $32.98
- TVRD N/A
- Revenue Growth
- BPRN N/A
- TVRD N/A
- 52 Week Low
- BPRN $27.25
- TVRD $8.13
- 52 Week High
- BPRN $39.35
- TVRD $34.31
- Technical
- Relative Strength Index (RSI)
- BPRN 51.83
- TVRD 64.50
- Support Level
- BPRN $32.86
- TVRD $28.20
- Resistance Level
- BPRN $33.48
- TVRD $31.54
- Average True Range (ATR)
- BPRN 0.77
- TVRD 1.75
- MACD
- BPRN -0.06
- TVRD 0.35
- Stochastic Oscillator
- BPRN 46.28
- TVRD 85.86
About BPRN Princeton Bancorp Inc. (PA)
Princeton Bancorp Inc is a banking company. It is a full-service financial institution that provides business and personal banking. Its personal banking and business banking services include checking accounts and savings accounts. It offers traditional retail banking services, one-to-four-family residential mortgage loans, multi-family and commercial mortgage loans, construction loans, commercial business loans, and consumer loans, including home equity loans and lines of credit. The Bank also has two retail branches and conducts loan origination activities in select areas of the New York City metropolitan area.
About TVRD Tvardi Therapeutics Inc. Common Stock
Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.